Funding for this research was provided by:
European Foundation for the Study of Diabetes (74550801)
Horizon 2020 (667191)
Novo Nordisk Fonden (NNF17SA0031406)
Received: 19 November 2020
Accepted: 30 November 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: Ethical approvals were obtained from the Scientific Ethics Committee of the Central Denmark Region for the Addition-Pro study (Sundhedssekretariatet, De Videnskabsetiske Komitéer for Region Midtjylland, Skottenborg 26, DK-8800 Viborg, Denmark, journal no. 20080229) and from the local ethical committee for the Rigshospitalet cohort (De Videnskabsetiske Komitéer for Københavns og Fredriksberg Kommuner, Københavns Kommune, Sundhetsforvaltningen, Sjællandsgade 40, 2200 København N, Denmark, journal no. KF01-061/03). All participants provided written informed consent before participating in the studies.
: Not applicable.
: The authors declare that there is no duality of interest associated with this manuscript.